Jim Simons Protalix Bio Therapeutics, Inc. Transaction History
Renaissance Technologies LLC
- $63.6 Billion
- Q1 2024
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Protalix Bio Therapeutics, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 824,700 shares of PLX stock, worth $865,935. This represents 0.0% of its overall portfolio holdings.
Number of Shares
824,700
Previous 665,600
23.9%
Holding current value
$865,935
Previous $1.19 Million
12.32%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding PLX
# of Institutions
66Shares Held
9.27MCall Options Held
40.6KPut Options Held
10.1K-
Black Rock Inc. New York, NY3.31MShares$3.48 Million0.0% of portfolio
-
State Street Corp Boston, MA827KShares$867,9100.0% of portfolio
-
Geode Capital Management, LLC Boston, MA754KShares$791,8150.0% of portfolio
-
Gsa Capital Partners LLP London, X0494KShares$518,2490.05% of portfolio
-
Northern Trust Corp Chicago, IL458KShares$481,0520.0% of portfolio
About Protalix BioTherapeutics, Inc.
- Ticker PLX
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,753,400
- Market Cap $52.2M
- Description
- Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...